This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Life Sciences Accounting & Reporting Congress
March 2025
Philadelphia, PA

Angus Grant
Executive Vice President, Business Development at Teva Pharmaceuticals
Speaker

Profile

Angus Grant, Ph.D., joined Teva Pharmaceuticals, August 1st, 2023, as EVP BD. Angus previously served as Chief Business Executive at BeiGene since June 2020. Collectively, Angus brings more than 25 years of experience across multiple key functions in the biotech industry, including business development, corporate strategy, mergers, investing, alliance management, research and development, and regulatory affairs. Dr. Grant has overseen the end-to-end process for strategy and partnering, driving external innovation, collaborations and investments to bring impactful medicines to patients around the world. He is committed to partnering with the best minds in academia, biotech and pharma to bring the highest quality and most innovative therapies globally with partners who share a patient-centric vision and unwavering commitment to transformational science.

Agenda Sessions

  • Capital Markets & Investments

    12:15pm